After the recommendation of outside Monitor Judge Frederick B. Lacey, Peter R. Dolan will vacate the position of chief executive officer at Bristol-Myers Squibb, effective immediately. The board has appointed James M. Cornelius, a director of the company since January 2005 and chairman emeritus of Guidant Corp., to act as interim chief executive officer. Mr. Cornelius was chairman of the board and interim chief executive officer of Guidant from September 2004 through April 2006. He served a...